Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
5,900
Frequently Asked Questions
What is Market Cap of Medpace Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Medpace Holdings Inc market cap is $13.98B.
What is the 52-week high for Medpace Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Medpace Holdings Inc 52 week high is $501.30 as of September 12, 2025.
What is the 52-week low for Medpace Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medpace Holdings Inc 52 week low is $250.05 as of September 12, 2025.
What is Medpace Holdings Inc stock price today?
Medpace Holdings Inc stock price today is $492.12.
What was Medpace Holdings Inc stock price yesterday?
Medpace Holdings Inc stock price yesterday was $497.59.
What is the PE ratio of Medpace Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Medpace Holdings Inc’s P/E ratio is 37.00.
What is the Price-to-Book ratio of Medpace Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Medpace Holdings Inc P/B ratio is 80.8916.
What is the 50-day moving average of Medpace Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Medpace Holdings Inc 50-day moving average is $423.08.